TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT03424499

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Single-use catheter
Description: Each urethral catheterization will be done with a new sterile catheter in a period of 8 weeks. Frequency of urethral catheterization will depend of the conditions of each patient (from 3-5 per day). Patients and parents were instructed to use clean technique by hand washing with water and soup, and penis/vulva cleansing with antiseptic wipes. Researchers reinforced the intermittent catheterization technique before the trial.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Reused catheter
Description: Each catheter is programmed to last 1 week. Evaluation will last a period of 8 weeks. Frequency of urethral catheterization will depend of the conditions of each patient (from 3-5 per day). after catheterization. Each catheter was programmed to last a week. Patients and parents were instructed to use clean technique by hand washing with water and soup, and penis/vulva cleansing with antiseptic wipes. Researchers reinforced the intermittent catheterization technique before the trial.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Reused catheter
Description: Each catheter is programmed to last 1 week. Evaluation will last a period of 8 weeks. Frequency of urethral catheterization will depend of the conditions of each patient (from 3-5 per day). after catheterization. Each catheter was programmed to last a week. Patients and parents were instructed to use clean technique by hand washing with water and soup, and penis/vulva cleansing with antiseptic wipes. Researchers reinforced the intermittent catheterization technique before the trial.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Urine culture
Description: A midstream urine sample will be obtained using sterile catheterization for urine culture performed by health provider. Urine cultures will be done in days 0, 7, 14, 28, 42 and 56.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Urine culture
Description: A midstream urine sample will be obtained using sterile catheterization for urine culture performed by health provider. Urine cultures will be done in days 0, 7, 14, 28, 42 and 56.

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Urine culture
Description: A midstream urine sample will be obtained using sterile catheterization for urine culture performed by health provider. Urine cultures will be done in days 0, 7, 14, 28, 42 and 56.
Study: NCT02584829

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Avelumab
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Avelumab
Description: Given IV

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MCPyV TAg-specific Polyclonal Autologous CD8-positive T Cells
Description: Given IV

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation Therapy
Description: Undergo radiation therapy

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation Therapy
Description: Undergo radiation therapy

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Recombinant Interferon Beta
Description: Given via intra-tumor injection

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Recombinant Interferon Beta
Description: Given via intra-tumor injection
Study: NCT04866238

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Vestibular fixed appliances
Description: The fixed appliances will be applied in class1 malocclusion patients who have dental crowding, then they will be followed up for 12 months.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Clear aligners
Description: The clear aligners will be applied in class1 malocclusion patients who have dental crowding, then they will be followed up for 12 months.
Study: NCT03419299

Intervention type: OTHER
Intervention: Tube Feeding Application
Description: A smart device application was developed and used to help residents determine the best enteral nutrition prescription for patients admitted to the ICU
Study: NCT02120430

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Video
Description: The video was developed by a multidisciplinary team (psychologists, paediatricians, filmmaker). It was conceived as an aid to parenting in the first year of life, providing opportunities for parents to look at their own experiences. The video lasts 24 minutes and describes the birth of a new relationship between primary caregivers and their babies, in chronological order, starting from late pregnancy to the end of the first year. Caregiver-child interactions are shown from early contact after delivery to common care practices, with an emphasis on four specific activities, which are believed to improve child development and caregiver-child interaction: reading aloud to the baby, exposure to songs, rhymes and music, promotion of early socialization for parents and for children.
Study: NCT03457649

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study: NCT05017870

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KSR-001-03
Description: KSR-001-03
Study: NCT02120430

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Video
Description: The video was developed by a multidisciplinary team (psychologists, paediatricians, filmmaker). It was conceived as an aid to parenting in the first year of life, providing opportunities for parents to look at their own experiences. The video lasts 24 minutes and describes the birth of a new relationship between primary caregivers and their babies, in chronological order, starting from late pregnancy to the end of the first year. Caregiver-child interactions are shown from early contact after delivery to common care practices, with an emphasis on four specific activities, which are believed to improve child development and caregiver-child interaction: reading aloud to the baby, exposure to songs, rhymes and music, promotion of early socialization for parents and for children.
Study: NCT02909413

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Desﬂurane
Description: Anesthesia maintenance: After endotracheal intubation, half of the patients will be randomized into Desﬂurane Group. The gas flow rate of Desflurane group is 2 L/min, include 50％ O2 and 4～5％ Desflurane.
Study: NCT02735018

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Epinephrine 1:100,000
Description: Inferior alveolar nerve block with Epinephrine 1:100.000
Study: NCT02986685

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trimebutine Maleate
Description: Rabeprazole 20mg once daily was administered during the 8 weeks' screening stage ,then oral trimebutine maleate 200mg three times daily combined with rabeprazole 20mg once daily were administered to the experimental arm for 4 weeks.

Intervention type: DRUG
Group type: OTHER
Intervention: rabeprazole
Description: Rabeprazole 20mg once daily was administered during the 8 weeks' screening stage,and rabeprazole 20mg once daily was administered to other arm for additional 4 weeks.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: rabeprazole
Description: Rabeprazole 20mg once daily was administered during the 8 weeks' screening stage,and rabeprazole 20mg once daily was administered to other arm for additional 4 weeks.
Study: NCT04143763

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Ecological Momentary Intervention (EMI)
Description: Using the messaging function of mobile devices, EMI offers a framework to deliver health information to the target population, corresponding to each individual's demands in terms of type (e.g., photo, text and/or voice message), timing, duration, and frequency of the messages, which are different to the features from other interventions
Study: NCT01349582

Intervention type: PROCEDURE
Group type: OTHER
Intervention: flow diversion
Description: endovascular treatment with flow diversion including standard management of thrombo-embolic risk

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: flow diversion
Description: endovascular treatment with flow diversion including standard management of thrombo-embolic risk

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: conservative management
Description: conservative management is watchful observation of the aneurysm until indication for intervention arises

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: endovascular coiling
Description: standard endovascular coiling of aneurysm with any type of already approved coil. High porosity stents may be used as an adjunct technique to coiling

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: balloon parent vessel occlusion
Description: sacrifice of parent artery of aneurysm by endovascular balloon occlusion with or without bypass

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: surgical clipping
Description: clipping of the aneurysm following invasive brain surgery
Study: NCT02607332

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Study: NCT00514436

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Asthma coaching
Description: Inperson contact followed by telephone with approach by issues raised by family
Study: NCT01825655

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cetirizine

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo or sugar pill
Study: NCT04019652

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CS-3150
Description: Single, oral administration; 10-mg or 40-mg dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CS-3150
Description: Single, oral administration; 10-mg or 40-mg dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CS-3150
Description: Single, oral administration; 10-mg or 40-mg dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CS-3150
Description: Single, oral administration; 10-mg or 40-mg dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Description: Single, oral administration; 400 mg-tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Description: Single, oral administration; 400 mg-tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Description: Single, oral administration; 400 mg-tablet
Study: NCT01941355

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise training component
Description: The physical exercises consist of; deep breathing exercises and breathing exercises using incentive spirometry with expiratory positive pressure airway, cycling exercises during hospitalisation and an individualised exercise programme running from discharge to 4 weeks following surgery.
Study: NCT04019652

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Description: Single, oral administration; 400 mg-tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo matching moxifloxacin tablet
Description: Placebo tablets matching moxifloxacin tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo matching moxifloxacin tablet
Description: Placebo tablets matching moxifloxacin tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo matching moxifloxacin tablet
Description: Placebo tablets matching moxifloxacin tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo matching CS-3150
Description: Placebo tablets matching CS-3150 tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo matching CS-3150
Description: Placebo tablets matching CS-3150 tablets
Study: NCT03450915

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: M-001
Description: A recombinant protein containing 9 conserved epitopes from Influenza A and B that are common to the vast majority of influenza viruses.
Study: NCT01941355

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise training component
Description: The physical exercises consist of; deep breathing exercises and breathing exercises using incentive spirometry with expiratory positive pressure airway, cycling exercises during hospitalisation and an individualised exercise programme running from discharge to 4 weeks following surgery.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psycho-educative component
Description: The psycho-educative rehabilitation programme consists of four psycho-educative consultations with a specially trained nurse. The last consultation will take place 4 weeks following surgery.
Study: NCT03450915

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Saline
Description: 0.9% sodium chloride (NaCl)
Study: NCT04169061

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acthar
Description: Acthar gel for subcutaneous injection
Study: NCT01667393

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: IDEV SUPERA Stent

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Percutaneous Transluminal Angioplasty
Study: NCT01867814

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pneumoperitoneum
Description: Pneumoperitoneum 15 mmHg and 10 mmHg
Study: NCT02615795

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Tele Monitoring, using Tunstall monitoring device
Description: Monitoring of symptoms and physiological parameters at home, using Tunstall Healthcare telemedicine equipment. Patients perform physiological measurement. In addition, they correspond to a standardized questionnaire regarding disease specific symptoms. Data is assessed by the medical staff the same day. If the data indicates worsening in the patient's condition, the patient is contacted by phone. The assessment of the patient is made either on the specialist nurse level, or at a conference between the specialist nurse and a senior pulmonary doctor. There is no call center service.
Study: NCT02909413

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: sevoﬂurane
Description: Anesthesia maintenance: After endotracheal intubation, half of the patients will be randomized into Sevoﬂurane Group. The gas flow rate of Desflurane group is 2 L/min, 50％O2 and 1.7-2.0% Sevoflurane.
Study: NCT03828240

Intervention type: OTHER
Group type: OTHER
Intervention: HIP fracture REhabilitation Programme for the elderly with hip fractures
Description: Eight-week activity-based intervention for elderly with hip fractures; one intervention during the hospital stay, four interventions at the elderly's municipality.
Study: NCT01820780

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Natriuretic peptides levels to J7 and J14
Study: NCT03271788

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mindfulness, MBSR
Description: Participants (stroke patients and one of their closest relatives) will conduct an MBSR Course in Phase B
Study: NCT03307954

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ekso Therapy (Exoskeleton Suit)

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual Physiotherapy
Study: NCT01480557

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: liquefaction
Description: Cataract extraction surgery type

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Torsional ip
Description: A type cataract surgery using torsional ip technology
Study: NCT04358198

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Artificial intelligence
Description: The AI algorithm based on the convolutional neural network (CNN) will be used for analysis the pictures of gastric intestinal metaplasia and normal mucosa. Then AI will be used as a diagnostic tool for GIM during routine endoscopy by using pathology as a gold standard.
Study: NCT00824928

Intervention type: PROCEDURE
Intervention: Cryoablation / Cryotherapy
Description: Salvage Cryoablation of the prostate
Study: NCT01921946

Intervention type: DRUG
Group type: OTHER
Intervention: Fimasartan

Intervention type: DRUG
Group type: OTHER
Intervention: Fimasartan

Intervention type: DRUG
Group type: OTHER
Intervention: Rosuvastatin

Intervention type: DRUG
Group type: OTHER
Intervention: Rosuvastatin
Study: NCT01941355

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psycho-educative component
Description: The psycho-educative rehabilitation programme consists of four psycho-educative consultations with a specially trained nurse. The last consultation will take place 4 weeks following surgery.
Study: NCT04527328

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AKST1210
Description: AKST1210
Study: NCT02975336

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: M2951
Description: Participants who had received Placebo or M2951 (25 mg QD, 75 mg QD or 50 mg BID) during DBPC period were switched to receive 50 mg M2951 orally BID in LTE period for 104 weeks.
Study: NCT04113148

Intervention type: OTHER
Intervention: Physiological measurements from heel
Description: Measurements of blood flow, tissue oxygen saturation, temperature, pressure

Intervention type: OTHER
Intervention: Physiological measurements from heel
Description: Measurements of blood flow, tissue oxygen saturation, temperature, pressure

Intervention type: OTHER
Intervention: Physiological measurements from heel
Description: Measurements of blood flow, tissue oxygen saturation, temperature, pressure

Intervention type: OTHER
Intervention: Physiological measurements from heel
Description: Measurements of blood flow, tissue oxygen saturation, temperature, pressure
Study: NCT02975336

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: M2951
Description: Participants who had received Placebo or M2951 (25 mg QD, 75 mg QD or 50 mg BID) during DBPC period were switched to receive 50 mg M2951 orally BID in LTE period for 104 weeks.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: M2951
Description: Participants who had received Placebo or M2951 (25 mg QD, 75 mg QD or 50 mg BID) during DBPC period were switched to receive 50 mg M2951 orally BID in LTE period for 104 weeks.
Study: NCT01682070

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SUBLIVAC FIX phleum prat.
Description: Comparison of different dosages to placebo

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SUBLIVAC FIX phleum prat.
Description: Comparison of different dosages to placebo

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SUBLIVAC FIX phleum prat.
Description: Comparison of different dosages to placebo

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SUBLIVAC FIX phleum prat.
Description: Comparison of different dosages to placebo

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study: NCT00844285

Intervention type: DRUG
Intervention: Cimzia
Description: The associated drug description is a total of two 200 mg subcutaneous injections of Cimzia to total 400 mg.
Study: NCT02735018

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Epinephrine 1:200,000
Description: Inferior alveolar nerve block with Epinephrine 1:200.000
Study: NCT01900678

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: VytronUS Ablation System
Description: Pulmonary vein isolation.
Study: NCT03894098

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Nerve block
Description: High ankle nerve block

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Nerve block
Description: High ankle nerve block
Study: NCT01929096

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Compound Edaravone Injection
Study: NCT04527328

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham Control (No Intervention)
Description: A covered surrogate object of similar size and shape as the investigational device

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Hemodialysis
Description: Hemodialysis

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Hemodialysis
Description: Hemodialysis
Study: NCT00258388

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: custirsen sodium
Description: 640mg IV for 2 hours - Cycle 1: Days -7, -5, -3, 1, 8, 15 (4 week cycle)~Subsequent cycles:~weekly on days 1, 8, 15 (3 week cycles)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: docetaxel
Description: 75mg/m2 IV for 1 hour - Day 1 every 3 weeks (3 week cycles)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: docetaxel
Description: 75mg/m2 IV for 1 hour - Day 1 every 3 weeks (3 week cycles)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: prednisone
Description: 5mg PO BID

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: prednisone
Description: 5mg PO BID
Study: NCT01608490

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: RePneu Lung Volume Reduction Coil System
Description: The LVRC group will undergo two bronchoscopic sessions under general or moderate sedation. During the procedure, subjects will be treated with Coils according to the Instructions for Use.
Study: NCT03433547

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Buckle
Description: Surgical procedures of macular buckling
Study: NCT01374217

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tadalafil
Description: Tadalafil will be administered at a dose of 20 mg orally daily starting with day 1 of the first cycle. Each cycle will last for 28 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenalidomide
Description: Lenalidomide will be administered as it was prior to study entry.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Dexamethasone will be administered as it was prior to study entry.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clarithromycin
Description: Clarithromycin will be administered as it was prior to study entry.
Study: NCT01929096

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Compound Edaravone Injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Compound Edaravone Injection

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Edaravone Injection
Study: NCT02971397

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Marrow Aspiration and Biopsy
Description: Undergo bone marrow aspiration and biopsy

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cytarabine
Description: Given IV
Study: NCT02595840

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Afatinib

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed